top of page

Executive Team

Under the leadership of Chief Executive Officer Thane Wettig, FibroGen’s executive team includes accomplished leaders with deep and broad experience. Supported by a staff of approximately 300 employees worldwide, we are focused on delivering first-in-class medicines for the treatment of unmet medical needs.

Thane Wettig

Chief Executive Officer

Christine L. Chung

Senior Vice President,
China Operations

David D_edited.jpg

David DeLucia, CFA

Chief Financial Officer

John Alden Headshot_edited_edited.jpg

John Alden

General Counsel

Our Leadership

We are putting substantial expertise to work in
developing and commercializing novel therapeutics.
 

bottom of page